Terence J. Harrist - Concepedia

Author

Terence J. Harrist

Also Known As

T J Harrist, T. J. HARRIST, T. J. Harrist, T.J. HARRIST, T.J. Harrist, TERENCE J. HARRIST, Terence Harrist, Terence J Harrist, Terence J. Harrist, Terence Jay Harrist

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University New York University Brigham and Women's Hospital University of Massachusetts Boston

About

Terence J. Harrist is an author at Massachusetts General Hospital specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	31	2.7K
2	Allergy	6	6	462
3	Engineering	1	1	176
4	Health Sciences	1	1	37
5	Anatomy	1	1	29

Terence J. Harrist

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. John J. Costa, George D. Demetri, Terence J. Harrist, The Journal of Experimental Medicine Mast Cell DisorderAdult Stem CellImmunologyKit LigandDermatology	1996	271
Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: The “LAMB” syndrome Arthur R. Rhodes, Robert A. Silverman, Terence J. Harrist, Journal of the American Academy of Dermatology Multiple Blue NeviSurgical PathologyPathologyCardiomucocutaneous MyxomasMedicine	1984	245
The malignant potential of small congenital nevocellular nevi Arthur R. Rhodes, Arthur J. Sober, Calvin L. Day, Journal of the American Academy of Dermatology Developmental AnomalyNeuro-oncologySurgical PathologyHistopathologyVascular Malformation	1982	231
Malignant Melanoma Calvin L. Day, Terence J. Harrist, Fred Gorstein, Annals of Surgery	1981	203
Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas Arthur R. Rhodes, Terence J. Harrist, Calvin L. Day, Journal of the American Academy of Dermatology Dysplastic Melanocytic NeviDermoscopic ImageSkin CancerSurgical PathologyHistopathology	1983	201
Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions Calvin L. Day, Martín C. Mihm, Arthur J. Sober, Annals of Surgery	1982	193
Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. D. J. Ruiter, Atul K. Bhan, Terence J. Harrist, The Journal of Immunology ImmunologyPathologyMalignant MelanomaDermatologyT Cells	1982	192
Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy Terence J. Harrist Archives of Dermatology	1982	186
Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis Calvin L. Day, Martín C. Mihm, Robert Lew, Annals of Surgery	1982	184
Comparative Histological Studies of the Tunable Dye (at 577 nm) Laser and Argon Laser: The Specific Vascular Effects of the Dye Laser Jeffrey L. Greenwald, Seymour Rosen, R. Rox Anderson, Journal of Investigative Dermatology Dye LaserEngineeringOphthalmologyArgon LaserLaser Photochemistry	1981	176

Page 1